Incyte Corporation
INCY
$59.61
-$2.50-4.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.41B | 4.24B | 4.08B | 3.86B | 3.77B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.41B | 4.24B | 4.08B | 3.86B | 3.77B |
| Cost of Revenue | 2.74B | 2.72B | 2.72B | 2.49B | 1.75B |
| Gross Profit | 1.67B | 1.52B | 1.36B | 1.36B | 2.02B |
| SG&A Expenses | 1.26B | 1.24B | 1.21B | 1.17B | 1.14B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.20B | 4.16B | 4.09B | 3.82B | 3.06B |
| Operating Income | 209.72M | 84.45M | -11.29M | 33.54M | 712.86M |
| Income Before Tax | 314.66M | 316.63M | 273.86M | 351.14M | 1.02B |
| Income Tax Expenses | 293.39M | 284.02M | 241.38M | 253.84M | 273.07M |
| Earnings from Continuing Operations | 21.27 | 32.62 | 32.48 | 97.30 | 745.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.27M | 32.62M | 32.48M | 97.30M | 745.44M |
| EBIT | 209.72M | 84.45M | -11.29M | 33.54M | 712.86M |
| EBITDA | 303.28M | 177.60M | 80.49M | 124.19M | 801.76M |
| EPS Basic | 0.37 | 0.31 | 0.17 | 0.38 | 3.33 |
| Normalized Basic EPS | 1.23 | 0.81 | 0.48 | 0.58 | 2.49 |
| EPS Diluted | 0.32 | 0.27 | 0.14 | 0.36 | 3.30 |
| Normalized Diluted EPS | 1.18 | 0.78 | 0.46 | 0.56 | 2.46 |
| Average Basic Shares Outstanding | 797.67M | 828.44M | 859.51M | 890.96M | 896.04M |
| Average Diluted Shares Outstanding | 809.63M | 838.66M | 867.36M | 897.69M | 905.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |